0.0050
0.0000
(0.00%)
At close: April 17 at 11:06:40 AM EDT
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Total Revenue
17,916.1010
19,350.9160
16,881.5640
12,537.9370
11,975.0210
Cost of Revenue
15,179.9860
16,408.9530
18,248.3170
9,847.5120
7,155.0540
Gross Profit
2,736.1140
2,941.9630
-1,366.7530
2,690.4250
4,819.9670
Operating Expense
4,841.8840
5,258.3140
8,099.0180
7,780.3990
8,440.4430
Operating Income
-2,105.7700
-2,316.3510
-9,465.7710
-5,089.9740
-3,620.4760
Net Non Operating Interest Income Expense
-546.7580
-488.6180
-1,830.7030
-1,743.0770
-2,106.7080
Other Income Expense
514.2800
550.8840
-2,775.2960
-10,683.6230
-78.2390
Pretax Income
-2,110.7180
-2,254.0850
-14,071.7700
-17,516.6740
-5,805.4230
Tax Provision
-1,630
-1,630
515.5340
549
482
Net Income Common Stockholders
-889.7950
-1,142.0030
-13,363.9200
-17,806.9220
-6,467.9230
Diluted NI Available to Com Stockholders
-889.7950
-1,142.0030
-13,363.9200
-17,806.9220
-6,467.9230
Basic EPS
0.00
0.00
-0.03
-0.04
-0.02
Diluted EPS
0.00
0.00
-0.03
-0.04
-0.02
Basic Average Shares
492,382.2300
477,763.3360
455,694.9470
450,684.5120
387,006.2290
Diluted Average Shares
492,382.2300
477,763.3360
455,694.9470
450,684.5120
387,006.2290
Total Expenses
20,021.8700
21,667.2670
26,347.3350
17,627.9110
15,595.4970
Net Income from Continuing & Discontinued Operation
-889.7950
-1,142.0030
-13,363.9200
-17,806.9220
-6,467.9230
Normalized Income
-957.2518
-1,280.6354
-11,283.5602
-9,780.7512
-6,191.3778
Interest Income
15.4470
--
--
16.4890
--
Interest Expense
546.7580
488.6180
1,830.7030
1,759.5660
2,106.7080
Net Interest Income
-546.7580
-488.6180
-1,830.7030
-1,743.0770
-2,106.7080
EBIT
-1,563.9600
-1,765.4670
-12,241.0670
-15,757.1080
-3,698.7150
EBITDA
152.5960
313.6710
-10,641.0540
-13,833.8600
-2,705.4080
Reconciled Cost of Revenue
13,557.5880
14,430.0990
16,848.2200
8,424.1100
6,660.2180
Reconciled Depreciation
1,716.5560
2,079.1380
1,600.0130
1,923.2480
993.3070
Net Income from Continuing Operation Net Minority Interest
-648.7840
-812.3840
-13,992.4690
-17,806.9220
-6,467.9230
Total Unusual Items Excluding Goodwill
514.1130
550.8840
-4,514.8480
-10,877.0440
-376.2520
Total Unusual Items
514.1130
550.8840
-4,514.8480
-10,877.0440
-376.2520
Normalized EBITDA
-361.5170
-237.2130
-6,126.2060
-2,956.8160
-2,329.1560
Tax Rate for Calcs
0.0004
0.0002
0.0004
0.0003
0.0003
Tax Effect of Unusual Items
205.6452
82.6326
-1,805.9392
-2,850.8732
-99.7068
7/31/2021 - 2/9/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IAN.CN iAnthus Capital Holdings, Inc.
0.0100
0.00%
NAV.V NAVCO Pharmaceuticals Inc.
0.0100
0.00%
2IA.F iAnthus Capital Holdings, Inc.
0.0005
0.00%
BBM.CN Blueberries Medical Corp.
0.0100
0.00%
CWEB.TO Charlotte's Web Holdings, Inc.
0.1200
0.00%
MYCO.CN Mydecine Innovations Group Inc.
0.0050
0.00%
CHALF Chalice Brands Ltd.
0.0000
0.00%
GHG.CN Global Hemp Group Inc.
0.0200
0.00%
KHRNF Khiron Life Sciences Corp.
0.0000
0.00%
RDDTF Radient Technologies Inc.
0.0000
0.00%